Does Dr. ZAKARI ALIYU have financial conflicts of interest?

Dr. ZAKARI ALIYU (MD) has received a total of $2,422 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,422 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ZAKARI ALIYU?

According to CMS Open Payments data, Dr. ZAKARI ALIYU received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($1,350), INCYTE CORPORATION ($168), and E.R. SQUIBB & SONS, L.L.C ($121).

Does Dr. ZAKARI ALIYU receive research grants or speaking fees?

Dr. ZAKARI ALIYU has received $2,422 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ZAKARI ALIYU

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: BALTIMORE, MD 21207

NPI Number: 1679539464

LIFETIME INDUSTRY VALUE

$2,422

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALIYU is a verified Internal Medicine, Hematology & Oncology practitioner based in BALTIMORE, MD.

Between 2021 and 2024, Dr. ALIYU had an overall industry promotional and research financial footprint of $2,422 as recorded in the federal CMS Open Payments database.

$2,422 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALIYU's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $1,350 (representing 55.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$1,350

55.8%

INCYTE CORPORATION

Rank 2

$168

6.9%

E.R. SQUIBB & SONS, L.L.C

Rank 3

$121

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.